Evidence map›Paper›PMID 15496520›Full record

ArticleRNA (New York, N.Y.)2004

Novel application of sRNA: stimulation of ribosomal frameshifting.

R C L Olsthoorn, M Laurs, F Sohet, C W Hilbers, H A Heus, C W A Pleij

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Translation Elongation and Recoding in Eukaryotes.Cold Spring Harbor perspectives in biology · 2018
    Review
  8. Article
  9. Article
  10. Review
  11. Reprogramming the genetic code: The emerging role of ribosomal frameshifting in regulating cellular gene expression.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
  12. Review
  13. Article
  14. Article
  15. Targeting frameshifting in the human immunodeficiency virus.Expert opinion on therapeutic targets · 2012
    Review
  16. Control of gene expression by translational recoding.Advances in protein chemistry and structural biology · 2012
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R C L OlsthoornLeiden Institute of Chemistry, Section Genexpress, Gorlaeus Laboratories, Leiden University, Einsteinweg 55, P.O. Box 9502, 2300RA Leiden, The Netherlands. olsthoor@chem.leidenuniv.nl
M Laurs
F Sohet
C W Hilbers
H A Heus
C W A Pleij
Leiden University · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small RNAs play an important role in regulation of gene expression in eukaryotic and eubacterial cells by modulating gene expression both at the level of transcription and translation. Here, we show that short complementary RNAs can also affect gene expression by stimulating ribosomal frameshifting in vitro. This finding has important implications for understanding the process of ribosomal frameshifting and for the potential application of small RNAs in the treatment of diseases that are due to frameshift mutations.

Indexed as

Base PairingCodonCodon, TerminatorEnhancer Elements, GeneticFrameshifting, RibosomalGene Expression RegulationOligonucleotidesOpen Reading FramesProtein BiosynthesisRecombinant Fusion ProteinsRibosomesRNA InterferenceRNA, MessengerRNA, Small InterferingThermodynamicsTranscription, GeneticCodonCodon, TerminatorOligonucleotidesRecombinant Fusion ProteinsRNA, MessengerRNA, Small Interfering

Identifiers

PMID15496520
PMCPMC1370657
OpenAlexW2151285173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.